Roche human epithelial factor receptor second protein gene two-color in situ hybrid nucleic acid probe combination - Taiwan Registration 8ad0960f609ff229ae2709a801b16dcb
Access comprehensive regulatory information for Roche human epithelial factor receptor second protein gene two-color in situ hybrid nucleic acid probe combination in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8ad0960f609ff229ae2709a801b16dcb and manufactured by ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
8ad0960f609ff229ae2709a801b16dcb
DHA00602311902
Product Details
The purpose of the Roche Human Epithelial Factor Receptor Second Protein Gene Two-color in Situ Hybrid Nucleic Acid Probe Combination is to quantify the amplification of human epithelial factor second protein (HER2) gene directly under light microscopy by formalin fixation and paraffin-embedded human breast cancer and gastric cancer tissue samples, including the gastroesophageal junction, with Roche Vantana automatic multifunctional histopathological staining system, using two-color in situ hybrid staining technology.
B Hematology, pathology, and genetics
B.1860 Immunopathological histochemistry reagents and kits
Contract manufacturing;; input
Dates and Status
Dec 26, 2011
Dec 26, 2021
Sep 08, 2023
Cancellation Information
Logged out
ๆชๅฑๅปถ่้พๆ่

